Suppr超能文献

疑似睡眠呼吸暂停患者是否需要进行甲状腺功能检查?

Are thyroid function tests necessary in patients with suspected sleep apnea?

作者信息

Winkelman J W, Goldman H, Piscatelli N, Lukas S E, Dorsey C M, Cunningham S

机构信息

Sleep Disorders Program, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Sleep. 1996 Dec;19(10):790-3. doi: 10.1093/sleep/19.10.790.

Abstract

Thyroid evaluation is frequently performed in patients with sleep apnea because of a suspected causal relationship between hypothyroidism and obstructive sleep apnea (OSA). The aim of this study was to determine the actual prevalence of hypothyroidism in patients referred for polysomnography and evaluate whether its rate was higher in patients with OSA than those without OSA. Ultrasensitive thyroid stimulating hormone (TSH) was performed on 255 of 279 consecutive patients referred for polysomnography from the neurology service of a large HMO. Hypothyroidism was detected in 1.6% (4/243) of all patients, 1.5% (3/194) of patients referred to evaluate OSA, and 2.0% of patients referred to evaluate the presence of periodic leg movement disorder (PLMD)/narcolepsy/parasomnia. There was no significant difference in rates of hypothyroidism in patients with documented OSA (2.9%, 3/103) compared to those without OSA (0.7%, 1/135). Two of the four patients with elevated TSHs had previously documented hypothyroidism and were on thyroxine replacement. Rates of hyperthyroidism were as high or higher than those of hypothyroidism in all groups. We conclude that thyroid screening does not appear to be appropriate for patients with suspected, or confirmed, OSA in the absence of signs or symptoms consistent with hypothyroidism or unless they are in a high risk group (women over the age of 60).

摘要

由于怀疑甲状腺功能减退与阻塞性睡眠呼吸暂停(OSA)之间存在因果关系,睡眠呼吸暂停患者经常进行甲状腺评估。本研究的目的是确定接受多导睡眠图检查患者中甲状腺功能减退的实际患病率,并评估OSA患者的患病率是否高于无OSA患者。对一家大型健康维护组织(HMO)神经科转诊进行多导睡眠图检查的279例连续患者中的255例进行了超敏促甲状腺激素(TSH)检测。在所有患者中,1.6%(4/243)检测到甲状腺功能减退,在转诊评估OSA的患者中,1.5%(3/194)检测到甲状腺功能减退,在转诊评估周期性肢体运动障碍(PLMD)/发作性睡病/异态睡眠的患者中,2.0%检测到甲状腺功能减退。有记录的OSA患者(2.9%,3/103)与无OSA患者(0.7%,1/135)的甲状腺功能减退患病率无显著差异。4例TSH升高的患者中有2例之前已记录有甲状腺功能减退且正在接受甲状腺素替代治疗。所有组中甲状腺功能亢进的患病率与甲状腺功能减退的患病率一样高或更高。我们得出结论,对于疑似或确诊为OSA但没有与甲状腺功能减退一致的体征或症状的患者,或者除非他们属于高危人群(60岁以上女性),甲状腺筛查似乎并不合适。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验